These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3454340)

  • 21. [Clinical study of combination chemotherapy with CDDP, ADM and CPM for ovarian cancer].
    Kobayashi H; Maeda M; Hayata T; Kawashima Y
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):829-36. PubMed ID: 3204307
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tumor chemotherapy of ovarian cancer patients in advanced age].
    Behling H; Schirmer A; Krafft W; Brückmann D
    Zentralbl Gynakol; 1988; 110(2):95-101. PubMed ID: 3364065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The potentials of combined chemotherapy in disseminated ovarian cancer].
    Gorbunova VA; Perevodchikova NI; Kozachenko VP; Ryzhakov VM; Marenich AF; Zhordania KI
    Akush Ginekol (Mosk); 1991 Feb; (2):54-7. PubMed ID: 1907433
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy of ovarian tumors using cis-platin].
    Laurová L; Kobilková J; Novotná J; Motlík K; Fricová M; Hornický J
    Cesk Gynekol; 1987 Feb; 52(1):41-4. PubMed ID: 3568161
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
    Conte PF; Bruzzone M; Chiara S; Sertoli MR; Daga MG; Rubagotti A; Conio A; Ruvolo M; Rosso R; Santi L
    J Clin Oncol; 1986 Jun; 4(6):965-71. PubMed ID: 3519886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group].
    Conte PF; Rosso R; Bruzzone M; Sertoli MR; Rubagotti A; Santi L; Carnino F; Cottini M; Mossetti C; Gatti M
    Minerva Ginecol; 1984 Apr; 36(4):213-6. PubMed ID: 6547773
    [No Abstract]   [Full Text] [Related]  

  • 27. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy with doxorubicin, etoposide and cyclophosphamide (DEC) in ovarian cancer persistent after platinum-based treatment.
    Zanetta G; Monico SL; Gabriele A; Miceli D; Mangioni C
    Eur J Cancer; 1996 Jan; 32A(1):178-9. PubMed ID: 8695232
    [No Abstract]   [Full Text] [Related]  

  • 29. The case for combination chemotherapy in the treatment of advanced ovarian cancer.
    Ozols RF
    J Clin Oncol; 1985 Nov; 3(11):1445-7. PubMed ID: 3932603
    [No Abstract]   [Full Text] [Related]  

  • 30. Tolerability of PLD/oxaliplatin regimen in recurrent ovarian cancer patients with previous fragility to carboplatin/paclitaxel treatment.
    Palma MD; Lombardi G; Donach ME; Borgato L; Zustovich F; Furini L; Nicoletto MO
    Am J Clin Oncol; 2011 Jun; 34(3):305-8. PubMed ID: 20622643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A combination of cyclophosphamide, adriamycin and platinum (CAP) in the treatment of stage III and IV ovarian cancer].
    Chylak V; Krusić J; Kolarić K
    Jugosl Ginekol Perinatol; 1988; 28(1-2):41-3. PubMed ID: 3398564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
    de Gramont A; Drolet Y; Louvet C; Dray C; Krulik M; Pigné A; Lavoie A; Painchaud M; Blouin R; Tessier C
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(1):105-9. PubMed ID: 3084619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The morphological aspects of a study of the efficacy of chemotherapy in ovarian cancer].
    Iakymova TP; Pavlova TD; Kartashov SM; Iakymov DIu
    Lik Sprava; 1996; (7-9):103-6. PubMed ID: 9072220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy for advanced ovarian cancer.
    Omura GA
    Lancet; 1987 Sep; 2(8560):689. PubMed ID: 2887974
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
    Inagaki J; Ogawa M; Horikoshi N; Ezaki K; Inoue K; Aiba K; Komyo M; Miyamoto H; Ikeda K; Kubo H
    Gan No Rinsho; 1983 Aug; 29(10):1291-5. PubMed ID: 6685195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of 28 years of treating advanced ovarian cancer.
    Krommer CF; Szalai JP
    Anticancer Res; 1993; 13(3):817-25. PubMed ID: 8317918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinoma.
    Edmonson JH; McCormack GW; Krook JE; Long HJ; Jefferies JA; Richardson RL
    Cancer Treat Rep; 1987 Feb; 71(2):199-200. PubMed ID: 3542210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
    Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():357-8. PubMed ID: 2693256
    [No Abstract]   [Full Text] [Related]  

  • 39. Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.
    Conte PF; Bruzzone M; Carnino F; Chiara S; Donadio M; Facchini V; Fioretti P; Foglia G; Gadducci A; Gallo L
    J Clin Oncol; 1991 Apr; 9(4):658-63. PubMed ID: 2066762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer].
    Hernádi Z; Juhász B; Póka R; Mahunka I; Lampé L
    Orv Hetil; 1987 Nov; 128(47):2457-61. PubMed ID: 3320851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.